Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-Q, Date: 2011-08-10
Original SEC Filing: Click here

---

Webplus: CPHI/20110810/10-Q/1/000.htm SEC Original: cphi10q063011.htm
FORM 10-Q (Mark One) x June 30, 2011 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)

---

---

Webplus: CPHI/20110810/10-Q/2_EX-3.1/000.htm SEC Original: cphi10qex31063011.htm
AMENDED AND RESTATED BYLAWS OF CHINA PHARMAS, (Effective August 9, 2011) SECTION 1. OFFICES 1.1. Registered Office. The registered office of therporation shall be established and maintained at 1209 Orange Street,rporation Trust Center, Wilmington, Newstleunty, Delaware 19801. 1.2. Principal Office. The principal office of therporation shall be located at the principal place of business of

---

---

Webplus: CPHI/20110810/10-Q/3_EX-31.1/000.htm SEC Original: cphi10qex311063011.htm
CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such

---

---

Webplus: CPHI/20110810/10-Q/4_EX-31.2/000.htm SEC Original: cphi10qex312063011.htm
CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such

---

---

Webplus: CPHI/20110810/10-Q/5_EX-32.1/000.htm SEC Original: cphi10qex321063011.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:August 10, 2011 ——————————– President and Chief Executive Officer cphi10qex321063011.htm 5 EX-32.1

---

---

Webplus: CPHI/20110810/10-Q/6_EX-32.2/000.htm SEC Original: cphi10qex322063011.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:August 10, 2011 ——————— (principal financial officer and principal accounting officer) cphi10qex322063011.htm 6 EX-32.2

---

Company Information:

Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-Q, Date: 2011-08-10CIK: 0001106644, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
2ND FLOOR, NO. 17, JINPAN ROAD, HAIKOU
HAINAN PROVINCE 570216